Effects of mTOR on Neurological Deficits after Transient Global Ischemia

Jihong Xing1, Jian Lu2

  • 1Department of Emergency Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, China.

Insights

Blocking the mammalian target of rapamycin (mTOR) pathway reduces brain damage and neurological deficits after cardiac arrest. This mTOR inhibition lessens inflammation, apoptosis, and improves vascular endothelial growth factor (VEGF) levels in the hippocampus.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • The mammalian target of rapamycin (mTOR) pathway regulates crucial cellular processes like growth, proliferation, and survival.
  • Activation of mTOR signaling is implicated in various pathological conditions, including brain injury.

Purpose of the Study:

  • To investigate the role of the mTOR pathway in brain injuries and neurological deficits following transient global ischemia induced by cardiac arrest (CA).
  • To evaluate the therapeutic potential of blocking mTOR signaling using rapamycin in a rat model of CA-induced ischemia.

Main Methods:

  • Transient global ischemia was induced in rats via asphyxia followed by cardiopulmonary resuscitation (CPR).
  • Expression levels of p-mTOR, phosphorylated 4E-binding protein 4 (4E-BP1), and p70 ribosomal S6 protein kinase 1 (S6K1) were assessed.
  • The effects of rapamycin treatment on pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), Caspase-3, vascular endothelial growth factor (VEGF), and its receptor VEGFR-2 were analyzed.
  • Neurological deficits and brain water content were evaluated.

Main Results:

  • mTOR pathway activation (increased p-mTOR, p-4E-BP1, p-S6K1) was observed in rats subjected to CA.
  • Rapamycin treatment attenuated the upregulation of pro-inflammatory cytokines and Caspase-3, indicating reduced inflammation and apoptosis.
  • Blocking mTOR with rapamycin promoted VEGF and VEGFR-2 levels in the hippocampus.
  • Rapamycin administration led to improved neurological function and reduced brain water content in CA rats.

Conclusions:

  • Activation of the mTOR signaling pathway contributes to the pathophysiology of CA-induced transient global ischemia.
  • Inhibition of the mTOR pathway with rapamycin demonstrates neuroprotective effects.
  • Targeting mTOR signaling pathways offers a promising therapeutic strategy for mitigating neural dysfunction and vulnerability associated with transient global ischemia.

Related Concept Videos

Introduction to Global Positioning System01:30

Introduction to Global Positioning System

The Global Positioning System (GPS) revolutionized positioning on Earth, providing precise location data through satellite ranging. The GPS system was developed in 1978 by the U.S. Department of Defense  for military use, and it became available for civilian applications in 1983, transforming fields including navigation, fleet management, and time synchronization for telecommunications systems.GPS consists of satellites in medium Earth orbit, about 20,200 kilometers above the surface,...
480
Global Climate Change01:50

Global Climate Change

Throughout its ~4.5 billion year history, the Earth has experienced periods of warming and cooling. However, the current drastic increase in global temperatures is well outside of the Earth’s cyclic norms, and evidence for human-caused global climate change is compelling. Paleoclimatology, the study of ancient climate conditions, provides ample evidence for human-caused global climate change by comparing recent conditions with those in the past.
28.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
810
Series R—L Circuit Transients01:22

Series R—L Circuit Transients

In a series resistor-inductor (R-L) circuit, closing the switch at the start of the time period simulates a three-phase short circuit, a fault condition where all three phases of an unloaded synchronous machine are short-circuited. When there is no fault impedance and no initial current, the initial voltage is determined by the phase angle of the source voltage.
Using Kirchhoff's Voltage Law (KVL) to analyze this circuit helps determine the total asymmetrical fault current, which consists...
386